Reticular

Reticular is revolutionizing drug discovery for pharmaceutical companies by providing interpretable AI solutions that leverage models like AlphaFold. Their technology enables researchers to steer these models with precision, similar to prompting large language models. Addressing the challenge of limited validation data, Reticular's platform reduces the costly trial-and-error process associated with traditional drug discovery. By offering AI interpretability, Reticular empowers early-stage biotechs to gain unprecedented control over biological functions. In a significant breakthrough, they identified the first interpretable features within protein models, unlocking precise control over biological functions just one week after their pivot. Founded by Nithin and John, who met during Biology Olympiads and spent four years as roommates at MIT, Reticular aims to unlock the full potential of biological models, which they believe contain vast amounts of untapped information. Their combined expertise in machine learning and biology, demonstrated through publications in NeurIPS and Nature, positions them to transform the future of drug development.